Literature DB >> 15674731

Two reciprocal translocations provide new clues to the high mutability of the Grid2 locus.

Kellie O Robinson1, Angela M Petersen, Stephanie N Morrison, Colleen M Elso, Lisa Stubbs.   

Abstract

We describe two new mutations, 153Gso and 154Gso, associated with reciprocal translocations with a common breakpoint in mouse chromosome 6B3 (Mmu6B3). The translocations arose independently in offspring of male mice treated with chlorambucil and glycidamide, respectively. Homozygotes of both mutant stocks display a characteristic gait ataxia with 'foot-patting' behavior; despite their ataxia the mutant animals are healthy, long-lived, and breed normally. Breeding experiments confirmed that 153Gso and 154Gso mutations are allelic, and both fail to complement a known mutation hotfoot (ho), a Mmu6 mutation involving the glutamate receptor gene, Grid2, that is associated with a virtually identical phenotype. Our studies demonstrate that the 153Gso and 154Gso mutations disrupt the Grid2 gene at sites located more than 100 kb apart in intron 6 and intron 4 of the gene, respectively. The occurrence of two independent translocations from a relatively small colony within the same locus supports data suggesting the hypermutability of the Grid2 locus and suggest that the gene's large size make it an especially likely target for mutations involving genetic rearrangement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674731     DOI: 10.1007/s00335-004-2423-z

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  36 in total

1.  Mutation of a glutamate receptor motif reveals its role in gating and delta2 receptor channel properties.

Authors:  K Kohda; Y Wang; M Yuzaki
Journal:  Nat Neurosci       Date:  2000-04       Impact factor: 24.884

2.  Oscillating Purkinje neuron activity causing involuntary eye movement in a mutant mouse deficient in the glutamate receptor delta2 subunit.

Authors:  Takashi Yoshida; Akira Katoh; Gen Ohtsuki; Masayoshi Mishina; Tomoo Hirano
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

3.  Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine kinase family with distinctive structures and neuronal expression.

Authors:  P C Maisonpierre; N X Barrezueta; G D Yancopoulos
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

4.  Evidence that instability within the FRA3B region extends four megabases.

Authors:  Nicole A Becker; Erik C Thorland; Stacy R Denison; Leslie A Phillips; David I Smith
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

5.  Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene.

Authors:  J Zuo; P L De Jager; K A Takahashi; W Jiang; D J Linden; N Heintz
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

6.  The DCC gene: structural analysis and mutations in colorectal carcinomas.

Authors:  K R Cho; J D Oliner; J W Simons; L Hedrick; E R Fearon; A C Preisinger; P Hedge; G A Silverman; B Vogelstein
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

Review 7.  Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.

Authors:  Masafumi Matsuo
Journal:  IUBMB Life       Date:  2002-03       Impact factor: 3.885

Review 8.  The delta2 glutamate receptor: a key molecule controlling synaptic plasticity and structure in Purkinje cells.

Authors:  Michisuke Yuzaki
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

9.  The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production.

Authors:  Judy A Cam; Celina V Zerbinatti; Jane M Knisely; Silva Hecimovic; Yonghe Li; Guojun Bu
Journal:  J Biol Chem       Date:  2004-05-04       Impact factor: 5.157

10.  A stimulatory role for cGMP-dependent protein kinase in platelet activation.

Authors:  Zhenyu Li; Xiaodong Xi; Minyi Gu; Robert Feil; Richard D Ye; Martin Eigenthaler; Franz Hofmann; Xiaoping Du
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

View more
  5 in total

1.  Identification of candidate genes for alcohol preference by expression profiling of congenic rat strains.

Authors:  Lucinda G Carr; Mark W Kimpel; Tiebing Liang; Jeanette N McClintick; Kevin McCall; Melissa Morse; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2007-04-19       Impact factor: 3.455

2.  Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing.

Authors:  Peter J Campbell; Philip J Stephens; Erin D Pleasance; Sarah O'Meara; Heng Li; Thomas Santarius; Lucy A Stebbings; Catherine Leroy; Sarah Edkins; Claire Hardy; Jon W Teague; Andrew Menzies; Ian Goodhead; Daniel J Turner; Christopher M Clee; Michael A Quail; Antony Cox; Clive Brown; Richard Durbin; Matthew E Hurles; Paul A W Edwards; Graham R Bignell; Michael R Stratton; P Andrew Futreal
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

3.  A new mouse allele of glutamate receptor delta 2 with cerebellar atrophy and progressive ataxia.

Authors:  Yuka Miyoshi; Yoshichika Yoshioka; Kinuko Suzuki; Taisuke Miyazaki; Minako Koura; Kazumasa Saigoh; Naoko Kajimura; Yoko Monobe; Susumu Kusunoki; Junichiro Matsuda; Masahiko Watanabe; Naoto Hayasaka
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

4.  A Mouse Mutation That Dysregulates Neighboring Galnt17 and Auts2 Genes Is Associated with Phenotypes Related to the Human AUTS2 Syndrome.

Authors:  P Anne Weisner; Chih-Ying Chen; Younguk Sun; Jennifer Yoo; Wei-Chun Kao; Huimin Zhang; Emily T Baltz; Joseph M Troy; Lisa Stubbs
Journal:  G3 (Bethesda)       Date:  2019-11-05       Impact factor: 3.154

5.  The human δ2 glutamate receptor gene is not mutated in patients with spinocerebellar ataxia.

Authors:  Jinxiang Huang; Aiyu Lin; Haiyan Dong; Chaodong Wang
Journal:  Neural Regen Res       Date:  2014-05-15       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.